Netflix adds 5.3M subscribers in Q3 >>> READ MORE


10 Biotech Stocks With Game-Changing Dates in Q3

If you're looking to speculate in the inherent volatility of biotech stocks, here are ten impending events that could cause those fireworks. More 

Dipping Celgene Corporation (CELG) Stock Is Begging to Be Bought

Biotech stocks, including Celgene, are pulling back. CELG stock is one of the best dip-buying opportunities of the bunch. More 

Is the SPDR S&P Biotech (ETF) (XBI) Done Running?

Biotech stocks are booming, but resistance looms close. Time to take profits on the SPDR S&P Biotech (ETF) XBI calls, but also consider reloading. More 

5 Biotech Stocks That Are Roaring Back to Life

These biotech stocks are making their way past recent lows based on a potential pause in focus and action by Trump. More 

3 Biotech Trades to Diversify Your Portfolio

There’s always a bull market somewhere. At times, there are bulls and bears in the same sector, as is the case with these biotech stocks. More 

Is Teva Pharmaceutical Industries Ltd (ADR) Stock a Migraine Buy?

Teva's recent migraine drug data, while positive, didn't impress investors. What happened, and should you tussle with TEVA stock? More 

Stocks Climb During Trump’s First International Visit

In the end, the Dow Jones gained 0.4%, the S&P 500 gained 0.5%, the Nasdaq gained 0.8% and the Russell 2000 added 0.7%. More